Quantum BioPharma Yönetim

Yönetim kriter kontrolleri 4/4

Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jul 2021, has a tenure of 3.33 years. total yearly compensation is $599.87K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 6.29% of the company’s shares, worth €505.28K. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.

Anahtar bilgiler

Zeeshan Saeed

İcra Kurulu Başkanı

US$599.9k

Toplam tazminat

CEO maaş yüzdesi37.1%
CEO görev süresi3.3yrs
CEO sahipliği6.3%
Yönetim ortalama görev süresi3.2yrs
Yönetim Kurulu ortalama görev süresi3.2yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Zeeshan Saeed'un ücretlendirmesi Quantum BioPharma'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$600kUS$223k

-US$18m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$774kUS$239k

-US$27m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$1mUS$225k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$899kUS$212k

-US$28m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$41m

Dec 31 2019US$2mUS$249k

-US$34m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$25m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$503kUS$183k

-US$17m

Tazminat ve Piyasa: Zeeshan's total compensation ($USD599.87K) is about average for companies of similar size in the German market ($USD488.36K).

Tazminat ve Kazançlar: Zeeshan's compensation has been consistent with company performance over the past year.


CEO

Zeeshan Saeed (54 yo)

3.3yrs

Görev süresi

US$599,873

Tazminat

Mr. Zeeshan Saeed serves as Executive Co-Chairman at FSD Pharma Inc. since May 24, 2018 and serves as its President since July 27, 2021 and Chief Executive Officer since June 29, 2023. He serves as Co-Chai...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Zeeshan Saeed
Founder3.3yrsUS$599.87k6.29%
€ 505.3k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
€ 431.1k
Donal Carroll
CFO & COO3.3yrsUS$602.87k4.44%
€ 356.6k
Nathan Coyle
Controllerless than a yearUS$178.21k0.13%
€ 10.8k
Lakshmi Kotra
CEO of Lucid & Director3.2yrsUS$521.97k1.17%
€ 94.3k
Jason Sawyer
Head of Finance & Mergers and Acquisitionsless than a yearVeri yokVeri yok
Maryann Adesso
Corporate Secretaryno dataVeri yokVeri yok
Randell Mack
President of FSD BioSciences3.7yrsVeri yokVeri yok
Andrzej Chruscinski
Vice President of Clinical & Scientific Affairs of Lucidno dataUS$110.30k0%
€ 0
Kevin Cassidy
Vice President of Quality-Lucidno dataUS$144.82kVeri yok

3.2yrs

Ortalama Görev Süresi

48yo

Ortalama Yaş

Deneyimli Yönetim: 0K91's management team is considered experienced (3.2 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Zeeshan Saeed
Founder3.5yrsUS$599.87k6.29%
€ 505.3k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
€ 431.1k
Lakshmi Kotra
CEO of Lucid & Director2yrsUS$521.97k1.17%
€ 94.3k
Daniele Piomelli
Member of Research & Clinical Advisory Board2.8yrsVeri yokVeri yok
Eleanor Fish
Member of Research & Clinical Advisory Board3yrsVeri yokVeri yok
Hance Clarke
Member of Research & Clinical Advisory Board3.2yrsVeri yokVeri yok
Eric Hoskins
Independent Director1.5yrsVeri yokVeri yok
Adnan Bashir
Independent Director3.4yrsUS$139.37k0.0077%
€ 620.5
Peter Stys
Member of Research & Clinical Advisory Board3.2yrsVeri yokVeri yok
Shannon Dunn
Member of Research & Clinical Advisory Board3.2yrsVeri yokVeri yok
Albert Wong
Member of Research & Clinical Advisory Board3.2yrsVeri yokVeri yok
Joga Gobburu
Member of Regulatory Advisory Board3yrsVeri yokVeri yok

3.2yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 0K91's board of directors are considered experienced (3.2 years average tenure).